EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review

Qiqing Sun iD, Zhenhua Xie, Lifang Song, Dapeng Fu

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2432 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Qiqing Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou,…. Hauptthemen laut MEDLINE: Muscular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the clinical and genetic characteristics of a patient with Polyglucosan body myopathy 1 (PGBM1) caused by a novel compound heterozygous variant in the RBCK1 gene.

Methods

The clinical data of the patient were collected, next‐generation sequencing technology was used to determine the exome sequence of the patient, and the suspected pathogenic locus was verified by Sanger sequencing.

Results

Through whole‐exome sequencing, we found that there were c.919G>T; p. (Glu307*) and c.723_730dup; p. (Glu244fs) variants of the RBCK1 gene in the patient, inherited from his parents, constituting a compound heterozygous variation. According to the guidelines of the American College of Medical Genetics and Genomics (ACMG), the two variants were rated as pathogenic, but there were no comparable cases. Previous literature reported 24 patients with RBCK1 gene variants, involving a total of 20 myocardial and 18 skeletal muscle cases.

Conclusions

The patient was twice diagnosed with cardiac insufficiency, neglecting the usual manifestations of muscle weakness, resulting in misdiagnosis. Later, novel variants in the RBCK1 gene were discovered through whole‐exome sequencing, and symptomatic treatment was given after diagnosis. The importance of whole‐exome sequencing technology in disease diagnosis and genetic counseling was emphasized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular DiseasesHumansGlucansMuscle, SkeletalMyocardiumTranscription FactorsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

RBCK1 genepolyglucosan body myopathy 1whole‐exome sequencing

Substanzen

polyglucosanGlucansRBCK1 protein, humanTranscription FactorsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Cardiology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, Henan, China.
  • Henan Children's Neurodevelopment Engineering Research Center, Henan Provincial Clinical Research Center for Pediatric Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzho…
  • Department of Neurology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, Henan, China.

ORCID-Profile: Qiqing Sun

Zitieren

APA

Sun, Q., Xie, Z., Song, L., & Fu, D. (2024). A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2432

Vancouver

Sun Q, Xie Z, Song L, Fu D. A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2432

BibTeX
@article{Sun2024,
  author = {Sun, Qiqing and Xie, Zhenhua and Song, Lifang and Fu, Dapeng},
  title = {A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2432}
}
Kostenlos starten →